Lincoln Shaw
Retina Specialist · Milwaukee, WINPI 1003347584
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Alimera Sciences, Inc. at 36.9% of the total. Reporting peaked in 2023 at $5,713 and has fallen 53.5% since, to $2,656 in 2025. Among retina specialist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $210.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$5K
- Astellas Pharma US Inc$3K
- Apellis Pharmaceuticals, Inc.$2K
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$999
- Alcon$704
- plus $2K from 12 others
Across 50 payments — averaging $1069.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$53K
What the payments were for
- Consulting fees$2,08415%
- Speaking & faculty fees$5,34838%
- Travel & lodging$6935%
- Food & beverage$5,94042%
- Entertainment$711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 8 | $5,213 |
| Astellas Pharma US Inc | 14 | $2,876 |
| Apellis Pharmaceuticals, Inc. | 3 | $1,610 |
| AbbVie(2 entities) | 11 | $1,207 |
| Regeneron Healthcare Solutions, Inc. | 9 | $999 |
| Alcon | 5 | $704 |
| Eyepoint US, Inc. | 3 | $367 |
| Mallinckrodt Hospital Products Inc. | 2 | $282 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $248 |
| Novartis | 2 | $242 |
| Genentech USA, Inc. | 1 | $115 |
| Biogen | 1 | $92 |
| Optos, Inc. | 1 | $71 |
| ANI Pharmaceuticals, Inc. | 1 | $49 |
| Coherus Oncology, Inc. | 1 | $22 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
| Sight Sciences, Inc. | 1 | $14 |
| NEW World Medical,inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,135 in reported general payments places this provider in the 95th percentile of 24 retina specialist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 86 | $2,924 |
| Ketorolac Tromethamine | 36 | $1,138 |
| Timolol Maleate | 51 | $247 |
| Brimonidine Tartrate | 18 | $121 |
| Latanoprost | 23 | $82 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Milwaukee
- Jennifer AdeghateMilwaukee$52K
- Nicholas TosiMilwaukee$5K
- Sharath RajaMilwaukee$634
- Christopher LangloMilwaukee$485
- Jonathan HersheyMilwaukee$22
- Rajeev BuddiNeenah$8K
- John RosculetNeenah$8K
- Clinton WarrenKenosha$5K
- Wei Chuan WangGreen Bay$3K
- Benjamin ErnstAppleton$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.